Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep-Oct;128(1-2):199-203.
doi: 10.1016/j.ejogrb.2005.11.032. Epub 2006 Jan 4.

Insufficient efficacy of intravenous ketanserin in severe early-onset pre-eclampsia

Lidwien M Hanff  1 , Willy Visser, Danielle W E Roofthooft, Andras Vermes, Wim C J Hop, Eric A P Steegers, Arnold G Vulto
Affiliations

Insufficient efficacy of intravenous ketanserin in severe early-onset pre-eclampsia

Lidwien M Hanff et al. Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct.

Abstract

Objective: To analyze the efficacy of intravenous ketanserin in controlling blood pressure of severe early-onset pre-eclamptic patients.

Study design: Pre-eclamptic patients (n=47) with a gestational age (GA) between 21 and 32 weeks were treated with intravenous ketanserin in a maximum dosage of 14 mg/h, to obtain a diastolic blood pressure of 90 mmHg or below. The number of patients reaching and maintaining target blood pressure was retrospectively assessed. Patient characteristics associated with an adequate or inadequate response to ketanserin treatment were identified.

Results: With a maximum intravenous dosage of ketanserin, target blood pressure was not achieved in 15 (32%) patients. A high systolic blood pressure at the start of treatment was significantly (p=0.02) associated with failure of ketanserin treatment. The median period of ketanserin treatment in the responding group was 3 days (range 1-10 days). In 26 (55%) of initially successfully treated patients, additional antihypertensive drugs had to be added to maintain adequate blood pressure control.

Conclusion: Intravenous ketanserin lacks antihypertensive efficacy in a substantial proportion of severe pre-eclamptic patients, despite high dosages. In patients who initially respond well to ketanserin treatment, additional antihypertensive treatment is often necessary to maintain adequate blood pressure control.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

LinkOut - more resources

-